无望感-自尊理论对抑郁症、焦虑症、强迫症患者的适用性研究  

The applicability of the integrated hopelessness/self-esteem theory to major depression disorder,anxiety disorders and obsessive-compulsive disorder

作　　者：周青静[1] 王纯[1] 关承斌[1] 李箕君[1] 张宁[1] 张婕[2] 

机构地区：[1]南京医科大学附属脑科医院医学心理科,210029 [2]青岛科技大学心理咨询中心

出　　处：《临床精神医学杂志》2011年第6期371-374,共4页Journal of Clinical Psychiatry

基　　金：江苏省自然科学基金(BK2008083);南京医科大学发展基金(2010NJM076)

摘　　要：目的:比较抑郁症、焦虑症、强迫症患者在归因方式、无望感、自尊上的异同,探索抑郁症、焦虑症、强迫症患者对无望感-自尊理论的适用性。方法:对门诊或住院的抑郁症(n=81)、焦虑症(n=53)、强迫症(n=48)患者,及正常对照组(n=51)被试进行归因方式问卷、自尊量表的测评,得分进行4组间比较。结果:①抑郁症组在归因方式总分、普遍维度和无望感得分与正常对照组之间差异具有统计学意义(P=0.02,0.02,0.03),焦虑症组和强迫症组普遍维度得分与正常对照组的差异具有统计学意义(P=0.03,0.03);②抑郁症组、焦虑症组、强迫症组的自尊水平均低于正常对照组(P均=0.00)。结论:本研究支持了无望感-自尊理论适用于抑郁症患者,但并不适用于焦虑症和强迫症患者。Objective：To compare the difference of attributional style,hopelessness and self-esteem between patients with major depression disorder（MDD） ,anxiety disorders（AD） and obsessive-compulsive disorder（OCD） and explore the applicability of the integrated hopelessness/self-esteem theory to MDD,AD and OCD. Method：Patients with MDD（n=81） ,AD（n=53） and OCD（n=48） and control group（n=51） were measured with attributional style questionnaire（ASQ） and self-esteem scale（SES） .The scores were compared between the 4 groups. Results：①There were significant differences in the scores of total ASQ,globe attribution,and hopelessness betweem MDD patients and control group（P=0.02,0.02,0.03） .Patients with AD and OCD were different significantly on globe attribution scores（P=0.03,0.03） .②Self-esteem socres were different significantly between patients groups（MDD,AD and OCD） and control group（P=0.00） . Conclusion：Patients with MDD,AD and OCD hold maladaptive attributional style,mainly in globe attribution.It is more obvious for MDD patients than AD and OCD patients.Only MDD patients feel hopeless.Patients with the three dieases has similar levels of low self-esteem.This study supports that the integrated hopelessness/self-esteem theory is applicable to MDD,but not to AD and OCD.

关 键 词：归因方式 自尊 无望感 抑郁症 焦虑症 强迫症 

分 类 号：R749[医药卫生—神经病学与精神病学]